Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Zafgen's promising obesity drug comes through in another midstage trial
Zafgen's promising obesity drug comes through in another midstage trial
Zafgen's promising obesity drug comes through in another midstage trial
Submitted by
admin
on January 7, 2015 - 9:23am
Source:
Fierce Biotech
News Tags:
Zafgen
obesity
beloranib
hypothalamic injury-associated obesity
Headline:
Zafgen's promising obesity drug comes through in another midstage trial
Do Not Allow Advertisers to Use My Personal information
